Gene Logic Q1 Revenues Fall 2 Percent as R&D Spending Swells | GenomeWeb

NEW YORK, April 22 (GenomeWeb News) - Gene Logic today said that first-quarter revenues fell 2 percent to $19.7 million from $20.2 million year over year.

Net loss for the three months ended March 31 improved 25 percent to $4 million, or $0.13 per basic share, from $5 million, or $0.18 per basic share, in the year ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.